The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, but its legacy within the broader market now raises questions about potential yields . Copycat versions are eroding exclusivity , leading to concerns that investing in companies significantly dependent to Viagra's former influence could be a speculative decision , e